Skip to main content
Csaba Kovesdy, MD, Nephrology, Memphis, TN

Csaba Pal Kovesdy MD


Fred Hatch Professor of Medicine/University of Tennessee Health Science Center

Join to view full profile
  • 956 Court AvenueSuite B226Memphis, TN 38163

  • Phone+1 901-448-2985

Dr. Kovesdy is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Csaba P. Kovesdy, MD, is the Fred Hatch Professor of Medicine in Nephrology and Chief of Nephrology at the University of Tennessee Health Science Center. He serves as the Director of the Clinical Outcomes and Clinical Trials Program in Nephrology and Medical Director of the Clinical Trials Unit at the University of Tennessee Health Science Center in Memphis, Tennessee. Dr. Kovesdy earned his medical degree Summa cum Laude from the University of Pecs Medical School in Pecs, Hungary. He completed his residency in Internal Medicine at the Henry Ford Hospital in Detroit, MI, and a clinical fellowship in Nephrology at the Johns Hopkins Bayview Medical Center in Baltimore, MD.
    Dr. Kovesdy’s research interests focus on the clinical investigation of disease mechanisms and outcomes in patients with pre-dialysis chronic kidney disease and ESRD. His research involves clinical trials, observational analyses of large administrative databases and translational research experiments in patients with all stages of kidney disease. He has published his research in over 700 peer-reviewed articles, as well as numerous abstracts and book chapters. He is a Fellow of the American Society of Nephrology, and a member of the European Renal Association, the International Society of Nephrology and the International Society of Renal Nutrition and Metabolism. Dr. Kovesdy is President-Elect of the International Society of Renal Nutrition and Metabolism, and a Co-Director of the Renal Total Nutrition Therapy Course.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Nephrology, 1999 - 2001
  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1996 - 1999
  • University of Pécs Medical School
    University of Pécs Medical SchoolClass of 1995, MD, Summa cum laude

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2012 - 2028
  • VA State Medical License
    VA State Medical License 2000 - 2028
  • MI State Medical License
    MI State Medical License 1996 - 1999
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Nephrology
    American Board of Internal Medicine Nephrology
  • Internal Medicine
    National Board of Physicians and Surgeons Internal Medicine
  • Nephrology
    National Board of Physicians and Surgeons Nephrology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association Between Malnutrition–Inflammation Score and Risk of Subsequent Self-Reported Bone Fractures in Prevalent Kidney Transplant Recipients  
    M Z Molnar, C P Kovesdy, Osteoporosis international
  • Publisher Correction: Genetic Analysis of over 1 Million People Identifies 535 New Loci Associated with Blood Pressure Traits  
    Csaba P Kovesdy, Walter Palmas, Nature
  • African Americans and Kidney Disease in the 21st Century: Articles from the 2017 Frank M. Norfleet Forum for Advancement of Health  
    Csaba Kovesdy, MD, American Journal of Kidney Diseases

Other

Authored Content

  • African Americans and Kidney Disease in the 21st Century: Articles from the 2017 Frank M. Norfleet Forum for Advancement of HealthOctober 2018
  • US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United StatesFebruary 2018

Press Mentions

  • Patiromer Use Reduced Potassium in Veterans with Hyperkalemia
    Patiromer Use Reduced Potassium in Veterans with HyperkalemiaDecember 5th, 2022
  • Uric Acid-Lowering Therapy May Increase Risk for CKD
    Uric Acid-Lowering Therapy May Increase Risk for CKDJune 17th, 2022
  • Underuse of Diabetic Kidney Disease Therapies Reported
    Underuse of Diabetic Kidney Disease Therapies ReportedApril 27th, 2022

Grant Support

  • Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets): A Pragmatic, Multi-Center, Randomized Controlled TrialVETERANS HEALTH ADMINISTRATION2022–2027
  • Clinical, Biochemical, and Microbiological Effects of Constipation Treatment in Patients with Chronic Kidney Disease: A Pilot Feasibility TrialUNIVERSITY OF TENNESSEE HEALTH SCI CTR2023–2026
  • Therapeutic Interventions to Access Outcomes and Disparities in Chronic Kidney Disease Among VeteransMEMPHIS VA MEDICAL CENTER2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: